Poster Session

Poster Session

 P-001

The frequency of AT deficiency in women with VTE in association with combined oral contraceptive use

P. Dulicek, E. Ivanova, P. Sadilek, Z. Fiedlerova

 

P-002

Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in Vitro Fertilization

S. Bouvier, O. Paulmyer-Lacroix, E. Kaspi, A. Bertaud, A. Leroyer, S. Robert, F. Dignat-George, M. Blot-Chabaud, J-C. Gris, N. Bardin

 

P-003

Incidence of cancer in women with a history of placenta-mediated complications: French national data

T. Boudemaghe, G. Seni, P. Fabbro-Peray, J.-C. Gris

 

P-004

Hydroxychloroquine for prevention of recurrent miscarriage: Study protocol of an ongoing French multicenter randomized placebo controlled trail

E. Pasquier, L. de Saint Martin, C. Chauleur, C. Bohec, F. Bretelle, V. Lejeune-Saada, J. Hannigsberg, C. Pimentel, G. Plu-Bureau

 

P-005

Is there a link between A5 FIBTEM and plasma fibrinolytic activity in severe postpartum haemorrhage?

T. Garin-Bastuji, AS. Baptiste, E. Jeanpierre, A. Bauters, S. Depret-Mosser, AS. Ducloy-Bouthors

 

P-006

Thrombotic risk factors in women receiving LMWH in high risk pregnancies. Post HOC analysis of a retrospective, multicenter study of 818 pregnancies in Greece

E.Papadakis, Α. Aktipi, G.Αnagnostou, P. Kotsi, A. Fifa, A. Christoforidou, E. Grouzi

 

P-007

Successful pregnancy outcome in a woman with inherited factor V deficiency

O. Pitiyarachchi, P. Motum, A. Adno, D. Hsu, R. Eslick

 

P-008

The OPTICA (OPTImised CTPA In Pregnancy) Study: Rationale and design of a prospective trial assessing the quality and safety of an optimised CTPA protocol in pregnancy

C.D. Gillespie, S. Foley, K. Ewins, M. Rowan, F. NiAinle, P.J. MacMahon

 

 

P-009

Venous thromboembolism in hospitalized women

C. Hotoleanu

 

P-010

Risk of developing thromboembolic complications in women of childbearing age who take combined oral contraceptives

Vorobyeva N.A., Marusii A.A.

 

P-011

Postpartum relapse of pregnancy related Thrombotic Thrombocytopenic Purpura with fatal intracranial bleeding: A case report

K. Skarmoutsou-Tsimirika , A. Dimosiari , K. Dinas, E. Mareti, M. Sidiropoulou, P. Doumtsis, C. Vettas, E. Mandala, A. Garyfallos , C. Kydona

 

P-012

Use of low molecular weight heparin in assisted reproductive technologies: Influence of different hormonal stimulation protocols

U. Scholz, M. Krause

 

P-013

Fibrinolysis and clot properties in women with some disorders

E. Roitman, M. Tanashyan, A. Shabalina, A. Momot

 

P-014

Gender differences in patients with venous thromboembolism and kidney disease

P. Demelo-Rodríguez, F. Galeano-Valle, E. Cervilla-Muñoz, R. Alonso-Beato, I. Jiménez-Hinarejos, A. García-García, J. Alonso-Muñoz, S. Pardo-Sánchez, J. del-Toro-Cervera

 

P-015

Recurrent DVT in young woman: Suboptimal therapeutic effect or genetic inheritance

G. Krstevski, M. Mancheva, D. Boneva, M. Bosevski

 

P-016

Systemic soluble mediators in HELLP syndrome - Case report 

L.M.S. Dusse, A. Teixeira-Carvalho, P.N. Alpoim, F.S. Mendes, L.L.F Coura, E.M. Lage, P. Teixeira, A. C. Campi-Azevedo, O.A. Martins-Filho

 

P-017

Are the polymorphisms in ACE and ESR1 genes associated with preeclampsia occurrence?

A.C.S. Lopes; L.O. Perucci; F.C.G. Evangelista; L.C. Godoi; A.P. Sabino; A. Talvani; L. M.S. Dusse; P.N. Alpoim

 

 

 

P-018

Longitudinal assessment of PlGF, sFlt-1 and sFlt-1/PlGF in pregnant women with risk factors for preeclampsia

F.S. Mendes, F.C. Lucena, E.M. Lage, P.G. Teixeira, R. Diniz, P.N. Alpoim, L.M.S. Dusse

 

P-019

Cryofibrinogenemia with severe acrocyanosis during pregnancy

D. Blickstein, G. Sarig, A. Jabareen, K. Toledano, M. Assalia, R. Hoffman, A. Karban, Y. Nadir

 

P-020

The management of pregnancy in a patient with hereditary combined deficiency of vitamin K dependent factors

R. Hoffman, MD; B. Brenner, MD

 

P-021

Hereditary thrombophilia, the ABO (RhD) blood group and pregnancy complications - Experience of our centre

S. Sretenović, G. Šošić, M. Varjačić

 

P-022

Primary thrombophilia increases the risk of pregnancy complications (gestational diabetes and pregnancy-induced hypertension) – Experience of a medical center

G.M. Sosic, S. Sretenovic, M. Varjacic

 

P-023

Consequences of the non-implemention of anti-thrombotic prophilaxis guidelines

MV. Cuevas, I. Martínez-Sancho, C. García-Díaz, B. Cuevas

 

P-024

Analysis of Venous Thromboembolic (VTE) disease in women in the first year of an outpatient clinic on VTE disease 

I. Grafia, F. Seguí, J. Aibar

 

P-025

Comprehensive care improves the prognosis of women with severe HELLP syndrome and postpartal thrombotic microangiopathic syndrome

J. Gumulec, O. Šimetka, D. Kaspřák, E. Doležálková, L. Gregorová, Z. Kořístek, M. Navrátil, M. Tvrdá, K. Notari, L. Broskevičová, L. Recová, K. Andělová, P. Kovářová, I. Lochman, J. Martínek, R. Hájek

 

P-026

Influence of genetic polymorphisms of the hemostasis system on the development of thrombotic complications when adopting combined oral contraceptives

N.A. Vorobyeva, D.R. Gamyrkina

 

P-027

Pre-implantation selection of a HPA 1a b/b embryo as an alternative to current treatment for neonatal alloimmune thrombocytopenia

E. Lefkou, K. Papanikolaou, D. Adamidou, A.  Varoudi, K. Pantos, K. Sfakinouis

 

P-028

Severe infections in pregnancy and the risk of venous thromboembolism (VTE)

V.V. Barros, E.A. Hase, A.M.K.Higai, P.P.Pereira, R.P.V. Francisco, M. Zugaib

 

P-029

Multiple pregnancies and the risk of venous thromboembolism (VTE): A non randomized controlled trial

V.V. Barros, M.H.B.Carvalho, A.M.K.Higai, S.E. Biancolin, R.P.V. Francisco, M. Zugaib

 

P-030

Obstetric antiphospholopid syndrome: Beyond the Sidney criteria

J. Ordoñez, T. Georgiett, MA. Molina, S. Ghione, MR. Hadad, LA. Del Val, MG. González

 

P-031

Haemoglobinopathies, red cell disorders, neutropenias and immune thrombocytopenias in pregnancy. One year review of obstetric haematology services in a tertiary centre

O. Al Shakhshir, QA. Hill, E. Ciantar

 

P-032

Non-anaemic iron deficiency – how different approaches to monitor iron deficiency in pregnancy identifies a cohort of iron deficient patients not picked up using national guidelines 

M. O’Sullivan, J.H. Barth, E. Ciantar

 

P-033

From thrombasthenia to next generation thrombocytopenia: Neonatal alloimmune thrombocytopenia induced by maternal Glanzmann thrombasthenia

A. Arie Barg, H. Hauschner, J. Luboshitz, T. Livnat, S. Levy‐Mendelovich, A. Lubetsky, N. Rosenberg, G. Kenet

 

P-034

Factors associated with the thrombosis in combined hormonal contraceptives users

N. Vereina, T. Movchan, V. Chulkov

 

P-035

Cerebral vein thrombosis and Arnold Syndrome as an early manifestation of 2 Neoplasm.

A case report

A.B. Vilaseca, M. Sanchez Casalongue   

 

 

P-036

Hydroxychloroquine: Improving pregnancy outcomes in refractory Obstetric Antiphospholipid Syndrome (OAPS)

M. Gerde, C. Heer, R. Alvarez, C. Fernandez Suarez, E. Ibarra, M. Iglesias

 

P-037

Inherited thrombophilia and VTE during pregnancy and postpartum period

K. Kartvelishvili, N. Pirtskhelani, N. Kochiashvili, N. Pargalava , M. Bokuchava, T. Mukhuradze

 

P-038

Calibrated automated thrombogram during pregnancy in unexplained recurrent miscarriages: A Pilot Study

A. Elias, MD, R. Hamoudi, MD, N. Schwartz, PHD, G. Ron MPH, M. Elias, MD

 

P-039

Infertile women with thrombophilia, autoimmune, inflammatory disease, and the role of LMWH to improve the pregnancy outcome

M. Hulíková, J. Hulíková

 

P-040

Characteristics of diagnostic method for determining antiphospholipid antibodies by the method of multiplex line blotting

Y.S. Dolgova, D.R. Eremeeva, M.S. Zainulina

 

P-041

Assessment of the knowledge about venous thromboembolism (VTE) on pregnant women attending Kigali Referral Hospitals

Christine ASHIMWE

 

P-042

Prediction of gestational VTED by RCOG guidelines

M. Casellas, S. Capote, M. Goya, A. Suy, E. Carreras

 

P-043

First trimester screening (FTS): Is the requested information of the medical history of antiphospholipid syndrome (APS) reported properly? Preliminary report

B. Grand, M. Arana

 

P-044

Aspirin-like defect in pregnancy and delivery - A case report

N. López-Muñoz, N. Castro Quismondo

 

 

 

 

P-045

The changes in platelet function during the three trimesters of uncomplicated pregnancy and puerperium compared to non-pregnant controls

D. Obeng-Tuudah, B. Hussein, A. Riddell, K. Gomez, R.A. Kadir

 

P-046

Proposed methodology to determine the optimal diagnostic strategy for pregnant women with suspicion of pulmonary embolism

S. Cohen, A. Spyropoulos, A. McCandlish, C. Feizullayeva, P. Sanelli, B. Brenner

 

P-047

Antithrombotic intervention for pregnancy complications: comparisons of various approaches

N. Vereina, V. Chulkov, V. Dolgushina, Vl. Chulkov, D. Ermakova, A. Kolesnokova

 

P-048

Thrombophilia and portal vein thrombosis – Clinical case

F. Bargado, I. Costa, A. Ribeiro, J. Lopes, F. Rincón, B. Ferro, R. Pardal, A. Mascarenhas, M. Romeiras, T. Araújo 

 

P-049

Autoimmune gastritis as reason of hyperhomocysteinemia and thrombotic risk factor in women: Case series

O. Dzhenina, V. Bogachev

 

P-050

Simultaneous using combined oral contraceptives and rivaroxaban in women with personal anamnesis of VTE

O. Dzhenina, V. Bogachev


Related Documents